{
  "url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-29",
  "json_url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-29.json",
  "legislation": "ukdsi/2024/9780348267167",
  "legislation_title": "The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024",
  "legislation_url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024",
  "path": "regulation/29",
  "kind": "regulation",
  "number": "29",
  "heading": "Amendment to regulation 40",
  "text": "In regulation 40 (grant or refusal of manufacturing authorisation), in paragraph (1)(a)(ii), after “Commission Directive 2003/94/EC” insert “in respect of Great Britain, or of Commission Delegated Regulation 2017/1569 in respect of Northern Ireland”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Regulation 40(1)(a)(ii) was substituted by S.I. 2006/1928."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2024/9780348267167/regulation/29",
    "retrieved_at": "2026-10-30T14:39:55.019280+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}